Seres Therapeutics
MCRB
#10246
Rank
ยฃ2.42 M
Marketcap
ยฃ0.28
Share price
1.11%
Change (1 day)
-61.36%
Change (1 year)

Revenue for Seres Therapeutics (MCRB)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of ยฃ98.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seres Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 ยฃ98.91 M1578.8%
2022 ยฃ5.89 M-94.51%
2021 ยฃ0.10 B340.61%
2020 ยฃ24.36 M-7.39%
2019 ยฃ26.31 M18.16%
2018 ยฃ22.26 M-6.24%
2017 ยฃ23.75 M34.65%
2016 ยฃ17.63 M
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ95 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ83.87 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.02 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA